7 Peroxisome proliferator-activated receptors (PPARs), G protein-coupled receptor 119 (GPR119) agonists, interleukin-1 Inhibitors, anorectic drugs, sodium-dependent glucose cotransporter-2 inhibitors, engineered zinc-finger protein transcription factors, fibroblast growth factor 21 (FGF-21), adenosine monophosphate kinase (AMPK) activators, and activators of SIRT1 (a member of the sirtuin family of NAD+-dependent protein deacetylases) are other currently available agents
Clinical trials of semaglutide therapy show average weight loss of 10-15% of baseline body weight over 68 weeks, with some patients achieving 20% or greater loss
Cappola, A.R., et al., Association of IGF-I levels with muscle strength and mobility in older women
Mol Psychiatry 2004
This side effect is temporary and often manageable with intentional lifestyle changes and medical guidance
Antibiotic solutions of Gatifloxacin (GFLX, 0.3% and 0.5%) and Levofloxacin (LVFX, 0.5% and 1.5%) were adsorbed onto hydrophilic acrylic and silicone IOLs